Life expectancy of major league baseball umpires.

UNLABELLED: Analysis of umpires' age at death suggests that fears regarding risks of their profession are unfounded. BACKGROUND: The on-field death 4 years ago of a veteran Major League Baseball (MLB) umpire raised questions regarding the mortality risks of this profession. OBJECTIVE: To determine if the life expectancy of MLB umpires differs from that of the general population. DESIGN: Ages of death of MLB umpires were determined, and the differences between the ages of death and age-adjusted life expectancies were calculated. T-score analysis was performed on these differences. Correlational analysis was also done on many different factors, including umpire debut year, debut age, life expectancy at debut, and length of career. RESULTS: No significant difference was found between the age at death of MLB umpires and their age-adjusted life expectancy. Correlational analyses showed that only length of career correlated with age at death. CONCLUSION: MLB umpiring is not associated with a shortened life expectancy. While this is most likely attributable to the profession having no inherent risk, it could also be explained by inherent risks being overcome by yet unidentified, unique factors.

The development and analysis of interactive videodisc technology to teach speechreading.

Members of the Department of Communication Disorders and Special Education and the Institute for Interactive Technologies at Bloomsburg University developed a computer-based interactive videodisc instructional program to teach speechreading skills. Speechreading Challenges on Videodisc provides users with practice in speechreading words, sentences, and stories presented by over 150 people in a user friendly environment. Unlike traditional videotapes, videodisc technology provides immediate feedback to the user. To determine the program's effectiveness in teaching speechreading, a comprehensive evaluation of the program was undertaken. Seventy-four college students participated in a study using the program to learn speechreading. Results indicated a statistically significant improvement in speechreading ability from pretest to posttest measures on both the videodisc program evaluation as well as on the Costello Test of Speechreading.

The statistical analysis of cancer inhibition/promotion experiments.

The purpose of this paper is to address the very important problem of accurate statistical analysis of certain types of cancer inhibition/promotion (IP) experiments. These experiments are routinely used by the National Cancer Institute to test the effects of potential chemopreventative agents. The statistical analysis is difficult since there is Type I censoring. In the IP experiments under investigation, laboratory animals (rats) are injected with a single dose of either a direct or indirect acting carcinogen. In the mammary tumor system, animals in the control group generally develop 5-7 tumors and typical experiments are usually terminated after 4-6 months. Animals are sacrificed at the end of the experiment and all observed tumors are confirmed. The two most common response variables are the number of observed tumors per animal and the rate of tumor development. The difficulty in analyzing these experiments occurs because experiments are terminated before all induced tumors have been observed. Fewer observed tumors in one group compared to another could be the result of a decreased number of induced tumors, a decrease in growth rate, or a combination of both. It is essential for the experimenter to distinguish between these two different biological actions. Present statistical techniques do not account for this confounding and since they rely primarily on nonparametric procedures, do not present an accurate description of potential IP agents. In this paper we introduce a parametric procedure that explicitly acknowledges the confounding present in experiments of this nature. The analysis is based on the comparison of the mean number of tumors per group (lambda) and the mean time to tumor appearance (mu). A longer mean time to development is believed to indicate a slower tumor growth rate. Hypothesis tests are developed to determine if there is an overall experiment effect, to isolate which groups are contributing to an observed experiment effect, and to isolate factors (tumor number and/or growth rate) contributing to an observed group difference. Confidence regions for (lambda, mu) are also generated. This analysis leads to a better understanding of how potential IP agents function.

A computer program for the statistical analysis of cancer inhibition/promotion experiments.

The computer program discussed and presented in this paper is designed for the statistical analysis of data from cancer inhibition/promotion experiments that involve Type I censoring. The theoretical derivation of the method is described in Biometrics 43 (1987) 525-534 and Appl. Math. Lett. 1 (1988) 197-201. Turbo Pascal is used to compute maximum likelihood estimates of the parameters of interest: the mean number of induced tumors per animal, and the mean time to tumor detection. The program conducts a likelihood ratio test to determine if there is an overall experiment effect, and allows the user to select options to isolate the pair(s) of groups contributing to the experiments effect, to isolate group differences in terms of tumor number and growth rate, and to graph 95% confidence regions for the vector parameter of interest.

The analysis of cancer chemoprevention experiments.

This paper is concerned with the analysis of certain cancer chemoprevention experiments that involve Type I censoring. In experiments of this nature, two common response variables are the number of induced cancers and the rate at which they develop. In this study we assume that the number of induced tumors and their times to detection are described by the Poisson and gamma distributions, respectively. Using the method of maximum likelihood, we discuss a procedure for estimating the parameters characterizing these two distributions. We apply standard techniques in order to construct a confidence region and conduct a hypothesis test concerning the parameters of interest. We discuss a method for comparing the effects of two different treatments using the likelihood ratio principle. A technique for isolating group differences in terms of the mean number of promoted tumors and the mean time to detection is described. Using the techniques developed in this paper, we reanalyze an existing data set in the cancer chemoprevention literature and obtain contrasting results.

A comparison of statistical techniques for analysis of growth curves.

Frequently, experiments are conducted in order to investigate the effects of various treatments on an animal's growth rate. The data from these investigations usually consist of each animal's body weight or accumulative weight gain at specific times during the experiment. The most common statistical techniques for analysis of growth rates (increments in body weight over time) consider only terminal body weights or final accumulative weight gain. In this study, we compare growth rates over the duration of the experiment and use standard simultaneous testing procedures in order to accommodate more than two treatment groups. Results obtained by comparison of regression lines randomization analysis of variance, and repeated measures analysis are presented.

Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat.

The relative effectiveness of either sodium selenite or selenomethionine in the inhibition of mammary carcinogenesis was studied in virgin female Sprague-Dawley rats. In one experiment, rats were given 50 mg of 1-methyl-1-nitrosourea per kg of body weight s.c. at 50 days of age. Beginning 7 days post-1-methyl-1-nitrosourea, they were assigned to a basal diet containing 0.1 ppm of selenium or basal diet supplemented to contain either 4, 5, or 6 ppm of selenium as sodium selenite or 5 or 6 ppm of selenium as selenomethionine. Selenium treatment was continued until termination of the study 135 days after 1-methyl-1-nitrosourea treatment. Sodium selenite, at the 5-ppm level, was the most effective chemopreventive agent. The highest level of selenomethionine (6 ppm) caused grossly apparent liver damage. No liver damage was noted in sodium selenite-treated rats. In a second experiment, rats were given 5 mg of 7,12-dimethylbenz(a)anthracene at 50 days of age. Beginning 7 days after 7,12-dimethylbenz(a)anthracene treatment, rats were assigned randomly to the control group or to one of two selenium treatment groups receiving either 3.4 ppm of selenium as sodium selenite or 3.4 ppm as selenomethionine in their drinking water. Selenium supplementation was continued throughout the study until its termination at 111 days postcarcinogen . Sodium selenite significantly reduced cancer incidence and the average number of cancers per rat. Treatment with selenomethionine was less effective and caused severe liver damage. Although both sodium selenite and selenomethionine can inhibit some aspect of the postinitiation stage(s) of mammary carcinogenesis, selenium provided as sodium selenite was the more effective and less toxic of the two chemicals. Increasing the dose of sodium selenite above 5 ppm did not enhance the inhibitory activity of selenium.

Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat.

The inhibitory activity of short-term feeding of one of four concentrations of dietary selenium against the induction of mammary gland carcinomas by 7,12-dimethylbenz(a)anthracene (DMBA) was studied in female Sprague-Dawley rats. When 28 days old, the animals were placed on a Torula yeast diet formulation which contained, by analysis, either 0.05, 0.15, 1.05, or 2.06 microgram of selenium, as sodium selenite, per g of diet. Mammary cancer was induced by a single p.o. administration of either 7.5 or 15.0 mg DMBA at 50 days of age. The animals were maintained on the above diets until 14 days after carcinogen treatment at which time all animals were transferred to a chow diet containing 0.21 microgram of selenium per g of diet. The study was terminated 120 days after DMBA administration. The concentrations of selenium in the liver and mammary tissue measured at the time of DMBA treatment increased with increasing levels of dietary selenium (p less than 0.05). At the low dose of DMBA, there was a trend towards reduction in the number of cancers with increased amounts of selenium, but the only significant difference occurred between groups fed the next to lowest and the highest level of selenium. At the high dose of DMBA, the number of observed cancers showed a strong dose effect (p less than 0.05). In addition, tumor load was significantly reduced in selenium-supplemented rats (p less than 0.05), and there was a significant delay (p less than 0.05) in the time to appearance of the cancers of animals receiving the highest level of selenium when compared with those receiving the lowest level. The dietary concentrations of selenium shown to inhibit the early stage(s) of cancer induction in this system were both significantly lower and fed for a shorter time interval than that which was previously reported.